Christopher Thomas Giordano serves as Executive at TENAX THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Christopher Thomas Giordano has executed 4 insider transactions totaling $20.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 9, 2026 involved receiving (via award) 450,000 shares valued at $0.
Christopher Thomas Giordano currently holds 450,000 shares of TENAX THERAPEUTICS, INC. (TENX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Thomas Giordano has been a net buyer of TENX stock. They have purchased $20.0K and sold $0 worth of shares.
Christopher Thomas Giordano's most recent insider trade was on Jan 9, 2026, when they sold 450,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $7.59 |
| Discretionary |
| Nov 19, 2025 | TENX | $3.4K | Purchase | 455 | $7.51 | Discretionary |
| Nov 18, 2025 | TENX | $12.5K | Purchase | 1,612 | $7.75 | Discretionary |